Asbestosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
Condition:   Malignant Pleural Mesothelioma, Advanced Interventions:   Drug: Oncolytic Adenovirus H101;   Drug: Programmed death receptor-1 inhibitor Sponsor:   Tianjin Medical University Second Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials